Regional institute of Ophthalmology, Indira Gandhi institute of Medical Sciences, Patna, Bihar, India.
London School of Hygiene & Tropical Medicine, London, United Kingdom.
Asia Pac J Ophthalmol (Phila). 2020 Sep-Oct;9(5):440-448. doi: 10.1097/APO.0000000000000313.
Retinopathy of prematurity (ROP) is vasoproliferative disease affecting preterm infants and is a leading cause of avoidable childhood blindness worldwide. The world is currently experiencing the third epidemic of ROP, where majority of the cases are from middle-income countries. Over 40% of the world's premature infants were born in India, China, Bangladesh, Pakistan, and Indonesia. Together with other neighboring nations, this region has unique challenges in ROP management. Key aspects of the challenges including heavier and more mature infants developing severe ROP. Current strategies include adoption of national screening guidelines, telemedicine, integrating vision rehabilitation and software innovations in the form of artificial intelligence. This review overviews some of these aspects.
早产儿视网膜病变（ROP）是一种血管增生性疾病，影响早产儿，是全球可避免儿童失明的主要原因。目前，世界正经历第三次 ROP 流行，其中大多数病例来自中等收入国家。全球超过 40%的早产儿出生在印度、中国、孟加拉国、巴基斯坦和印度尼西亚。该地区与其他邻国一样，ROP 管理方面存在独特的挑战。挑战的关键方面包括体重较重和更成熟的婴儿发展为严重 ROP。目前的策略包括采用国家筛查指南、远程医疗、将视力康复和人工智能形式的软件创新相结合。本文综述了其中的一些方面。
